Skip to main content
. 2017 Jun 10;4(2):39. doi: 10.3390/medicines4020039

Table 4.

ABTS radical scavenging of compounds 5a–d and 10.

Concentration (μM) Compounds
5a 5b 5c 5d 10
5 nt nt nt nt 2.39 ± 0.57
10 - - - - 27.81 ± 2.12 ***
50 11.74 ± 0.47 *** 9.69 ± 0.57 ** 4.18 ± 1.23 0.30 ± 0.33 87.59 ± 4.81 ***
100 22.84 ± 1.02 *** 22.32 ± 1.65 *** 11.60 ± 1.50 *** 3.10 ± 0.48 *** 94.03 ± 1.05 ***
500 77.61 ± 0.81 *** 73.92 ± 4.96 ** 59.51 ± 4.16 *** 17.05 ± 0.47 *** x
IC50 297.00 ± 1.00 315.30 ± 30.02 419.30 ± 35.80 - 25.00 ± 2.00

Notes: Data are represented as mean ± SD (n = 3). The values are expressed in percentage of inhibition in relation to control. IC50 = concentration compound required for 50% scavenging, in μM. The asterisks represent significant difference (**) p < 0.01; (***) p < 0.001 when compared with control sample by Student–Newman–Keuls test for post-hoc comparison. nt = not tested. x = sample blurred color.